Targets companies applying modern computation (AI, simulation) to agriculture, mining, manufacturing, health and defense, leveraging partners' hard‑science and national‑security expertise to navigate regulation and dual‑use challenges. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Spearheaded by a former Google X founder, the firm brings a moonshot lab prototyping philosophy anchored in a structured Triad investment thesis encompassing deep technology, reimagined unit economics, and climate-positive outcomes. It stands out by offering hands-on prototyping assistance and reverse-engineering of unit-economics models for its portfolio.
Invests from napkin-stage through IPO using an evergreen own-capital model for patient, flexible long-term support; active nascent-stage investor (~180 deals) oriented toward deep bio and frontier software/crypto. With a disciplined investment approach, the team drives value for both founders and investors.
Is dedicated to impactful businesses aiming to positively transform the world's food system.
Formative-stage investor oriented toward AI-driven health, mobility, fintech/insurtech and intelligent enterprise, delivering hands-on GTM and roadmap support from ex-corporate venture leaders and engineers leveraging Allianz's risk, data, and regulatory expertise. With a disciplined investment approach, the team drives value for both founders and investors.
Operator-led biotech fund run by ex-founders targeting young PhD/postdoc and emerging academic scientists, focusing on overlooked genomics, diagnostics and AI-in-biotech, delivering a Fellowship and academic partnerships With a disciplined investment approach, the team drives value for both founders and investors.
Specializes entirely on AI-first businesses in technical domains (defense, robotics, drug discovery, AI infrastructure), utilizing the entrepreneur’s extensive AI analysis visibility and a press arm that fosters lab-to-lab debates.
